Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 854,629 |
|
|||||
| News | - | ||||||
| Day High | 14.63 | Low High |
|||||
| Day Low | 13.95 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Viridian Therapeutics Inc | VRDN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.77 | 5.58% | 14.58 | 15:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.05 | 13.95 | 14.63 | 14.58 | 13.81 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,064 | 854,629 | US$ 14.36 | US$ 12,271,928 | - | 10.925 - 28.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:36:26 | 1 | US$ 15.01 | USD |
Viridian Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 915.15M | 62.77M | - | 314k | -237.73M | -3.79 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Viridian Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRDN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.61 | 14.63 | 12.20 | 13.30 | 894,394 | 1.97 | 15.62% |
| 1 Month | 16.41 | 17.33 | 12.20 | 14.78 | 785,860 | -1.83 | -11.15% |
| 3 Months | 17.82 | 21.46 | 12.20 | 17.23 | 908,809 | -3.24 | -18.18% |
| 6 Months | 12.91 | 24.18 | 12.20 | 18.19 | 918,385 | 1.67 | 12.94% |
| 1 Year | 28.52 | 28.99 | 10.925 | 18.88 | 827,616 | -13.94 | -48.88% |
| 3 Years | 18.16 | 39.00 | 9.47 | 20.54 | 509,673 | -3.58 | -19.71% |
| 5 Years | 21.39 | 39.00 | 9.47 | 20.52 | 468,917 | -6.81 | -31.84% |
Viridian Therapeutics Description
| Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease. |
